| Dr Kathleen Zaremba Ladas, MD | |
|
2101 Medical Park Dr, Suite 101, Silver Spring, MD 20902-4053 | |
| (301) 681-6600 | |
| (301) 681-3799 |
| Full Name | Dr Kathleen Zaremba Ladas |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 2101 Medical Park Dr, Silver Spring, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629093745 | NPI | - | NPPES |
| 0002 | Other | BLUE CROSS/BLUE SHIELD | |
| 180012563 | Other | MEDICARE - RAILROAD | |
| 228253 | Other | UNITED HEALTH CARE-MAMSI | |
| 180012563 | Other | DC | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | D30908 (Maryland) | Primary |
| Entity Name | Ladas Eye Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902837149 PECOS PAC ID: 6406822584 Enrollment ID: O20040909000655 |
News Archive
A new study may alleviate concerns regarding increased cancer risk for patients undergoing spinal fusion surgery with recombinant human bone morphogenetic protein (rhBMP). The study appears in November 15 issue of Spine, published by Wolters Kluwer.
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
The Magnetic Resonance Center of the University Children's Hospital Zurich has achieved a world first break through in MR-guided, non-invasive neurosurgery. Ten patients have been successfully treated by means of transcranial high-intensity focused ultrasound. This fully non-invasive procedure opens new horizons for neurosurgery and the treatment of different neurological brain disorders.
A new study from örebro University, published in Science Signaling today, shows that heart medication reduces the build-up of plaque in the brain's blood vessels in mice. The question is if this is true also in humans? If the answer is yes, it might bring scientists a step closer to developing a medicine against Alzheimer's disease.
Brain cells talk to each other in a variety of tones. Sometimes they speak loudly but other times struggle to be heard. For many years scientists have asked why and how brain cells change tones so frequently. Today National Institutes of Health researchers showed that brief bursts of chemical energy coming from rapidly moving power plants, called mitochondria, may tune brain cell communication.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kathleen Zaremba Ladas, MD 12117 Red Admiral Way, Germantown, MD 20876-5939 Ph: (301) 916-6160 | Dr Kathleen Zaremba Ladas, MD 2101 Medical Park Dr, Suite 101, Silver Spring, MD 20902-4053 Ph: (301) 681-6600 |
News Archive
A new study may alleviate concerns regarding increased cancer risk for patients undergoing spinal fusion surgery with recombinant human bone morphogenetic protein (rhBMP). The study appears in November 15 issue of Spine, published by Wolters Kluwer.
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
The Magnetic Resonance Center of the University Children's Hospital Zurich has achieved a world first break through in MR-guided, non-invasive neurosurgery. Ten patients have been successfully treated by means of transcranial high-intensity focused ultrasound. This fully non-invasive procedure opens new horizons for neurosurgery and the treatment of different neurological brain disorders.
A new study from örebro University, published in Science Signaling today, shows that heart medication reduces the build-up of plaque in the brain's blood vessels in mice. The question is if this is true also in humans? If the answer is yes, it might bring scientists a step closer to developing a medicine against Alzheimer's disease.
Brain cells talk to each other in a variety of tones. Sometimes they speak loudly but other times struggle to be heard. For many years scientists have asked why and how brain cells change tones so frequently. Today National Institutes of Health researchers showed that brief bursts of chemical energy coming from rapidly moving power plants, called mitochondria, may tune brain cell communication.
› Verified 6 days ago
Arusha Gupta, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8630 Fenton St, Suite 514, Silver Spring, MD 20910 Phone: 301-587-1220 | |
Aziz Alexander Khanifar, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8630 Fenton St Ste 1104, Retina Group Of Washington, Silver Spring, MD 20910 Phone: 301-495-2357 Fax: 301-495-2359 | |
Dr. Beth Alexandra Schwartz, M.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10101 Colesville Rd, Silver Spring, MD 20901 Phone: 301-754-0101 Fax: 301-754-0103 | |
Dr. William D O'donnell, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2101 Medical Park Dr, Silver Spring, MD 20902 Phone: 301-681-6600 Fax: 301-681-3799 | |
Dr. Thomas Yau, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8630 Fenton St, Suite 514, Silver Spring, MD 20910 Phone: 301-587-1220 Fax: 301-587-1269 | |
Dr. Aisha Macedo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2101 Medical Park Dr Ste 101, Silver Spring, MD 20902 Phone: 301-681-6600 | |
Julie G Gutmark, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8630 Fenton St, Suite 130, Silver Spring, MD 20910 Phone: 301-588-1177 Fax: 301-589-5245 |